Life Sciences IT & Services

Prioritizing 9 precision medicine technologies helping pharma leaders offer better patient outcomes

Research Brief

Prioritizing 9 precision medicine technologies helping pharma leaders offer better patient outcomes

From real-world data to digital therapeutics, this MVP Technology Framework evaluates the tech solutions pharmaceutical companies and contract research organizations (CROs) like Pfizer and IQVIA are using to develop and deliver personalized medicine.

Oct 28, 2022

130 companies accelerating drug discovery for pharma and CRO leaders

Report

130 companies accelerating drug discovery for pharma and CRO leaders

This report looks at the companies helping pharmaceutical companies and contract research organizations (CROs) discover new drugs.

Aug 22, 2022

Analyzing Microsoft’s growth strategy: How the OS titan is building a new foundation for healthcare

Research Brief

Analyzing Microsoft’s growth strategy: How the OS titan is building a new foundation for healthcare

We mined Microsoft's acquisitions, investments, and partnerships to discern the company's strategic priorities.

Aug 17, 2022

The Future of Clinical Trials: How technology is making drug trials more efficient, cost-effective, and inclusive

Report

The Future of Clinical Trials: How technology is making drug trials more efficient, cost-effective, and inclusive

We dive into the evolution of clinical trials and where the space is going next, from AI to improve recruitment to in silico trials with simulated patients.

Aug 12, 2022

Distributed clinical trial provider Curebase raises $40M in Gilead-backed round. Curebase competitors are Castor EDC, Clara Health, Evidation, Hawthorne Effect, Medable, ObvioHealth, Reify Health, Science 37, THREAD, TrialSpark, Verana Health, and VirTrial.

Research Brief

Distributed clinical trial provider Curebase raises $40M in Gilead-backed round. Curebase competitors are Castor EDC, Clara Health, Evidation, Hawthorne Effect, Medable, ObvioHealth, Reify Health, Science 37, THREAD, TrialSpark, Verana Health, and VirTrial.

Curebase plans to use the funds to move further into the pharma and biotech spaces. Here are the top-line bullets you need to know.

May 9, 2022

Clinical trial management software Reify Health reaches $4.8B valuation. Reify Health competitors are Curebase, Castor EDC, ObvioHealth, Hawthorne Effect, Evidation, and Science 37.

Research Brief

Clinical trial management software Reify Health reaches $4.8B valuation. Reify Health competitors are Curebase, Castor EDC, ObvioHealth, Hawthorne Effect, Evidation, and Science 37.

The company was last valued at $2.2B in August 2021. Here are the top-line bullets you need to know.

Apr 28, 2022

Mendel.ai, a real-world data company for clinical trial research, raises $40M. Mendel.ai competitors are ConcertAI, COTA, Medaptive Health, Saama Technologies, Vasta Global, and Verantos.

Research Brief

Mendel.ai, a real-world data company for clinical trial research, raises $40M. Mendel.ai competitors are ConcertAI, COTA, Medaptive Health, Saama Technologies, Vasta Global, and Verantos.

Mendel.ai plans to use the funds to accelerate the launch of its clinical information consolidation tool. Here are the top-line bullets you need to know.

Apr 27, 2022

DNAnexus hits $600M valuation for its cloud-based biomedical data analysis software. DNAnexus competitors include Seven Bridges, BC Platforms, and Lifebit.

Research Brief

DNAnexus hits $600M valuation for its cloud-based biomedical data analysis software. DNAnexus competitors include Seven Bridges, BC Platforms, and Lifebit.

This news comes on the heels of its Series I round. The funding will help DNAnexus support product development and international growth. Here are the top-line bullets you need to know.

Mar 17, 2022

Computational drug discovery platform Terray Therapeutics raises $60M from Madrona. Terray competitors include Verge Genomics, Certara, Insilico Medicine, Atomwise, Recursion, and Benevolent AI.

Research Brief

Computational drug discovery platform Terray Therapeutics raises $60M from Madrona. Terray competitors include Verge Genomics, Certara, Insilico Medicine, Atomwise, Recursion, and Benevolent AI.

Terray Therapeutics plans to use the funds to advance its preclinical therapeutics pipeline and its proprietary tNova platform. Here are the top-line bullets you need to know.

Feb 22, 2022

MVP Technology Framework: Clinical Trials for Pharma and CRO Leaders

Report

MVP Technology Framework: Clinical Trials for Pharma and CRO Leaders

This report uses the CB Insights MVP Technology Framework to rank tech market planning decisions and give an adoption playbook for the clinical trials domain.

Feb 16, 2022

Electronic Lab Notebook Firm Benchling Raises At A $6B Valuation — A Trailing Price/Revenue Valuation Multiple Of 122x

Research Brief

Electronic Lab Notebook Firm Benchling Raises At A $6B Valuation — A Trailing Price/Revenue Valuation Multiple Of 122x

The Series F round brings Benchling's total funding to $412M. Here are the top-line bullets you need to know.

Nov 23, 2021

Digital Clinical Research Platform For Drug Development Owkin Raises $180M At A Unicorn Valuation

Research Brief

Digital Clinical Research Platform For Drug Development Owkin Raises $180M At A Unicorn Valuation

Owkin has raised $254.1M in funding to date. Here are the top-line bullets you need to know.

Nov 23, 2021

DCM-Backed Mendel Raises $18M To Expand Its Clinical AI Platform

Research Brief

DCM-Backed Mendel Raises $18M To Expand Its Clinical AI Platform

The funding will be used to quadruple its team by Q1'22. Here are the top-line bullets you need to know.

Jun 9, 2021

Tiger Global-Backed Qualio Raises $50M For Its Quality Management Platform

Research Brief

Tiger Global-Backed Qualio Raises $50M For Its Quality Management Platform

The funding will help Qualio triple its headcount. Here are the top-line bullets you need to know.

May 28, 2021

New Enterprise Associates-Backed Aetion Raises $110M To Advance Its Biotechnology Platform

Research Brief

New Enterprise Associates-Backed Aetion Raises $110M To Advance Its Biotechnology Platform

The company has raised $212M to date for its real world evidence platform. Here are the top-line bullets you need to know.

May 13, 2021

Sequoia-Backed Benchling Raises $200M To Accelerate Cloud-Powered R&D In Life Sciences

Research Brief

Sequoia-Backed Benchling Raises $200M To Accelerate Cloud-Powered R&D In Life Sciences

Benchling attained unicorn status at a $4B valuation amid its IPO preparations. Here are the top-line bullets you need to know.

Apr 16, 2021

State Of Healthcare Report: Investment & Sector Trends To Watch

Report

State Of Healthcare Report: Investment & Sector Trends To Watch

Our healthcare report provides a data-driven look at global healthcare technology investment trends, top deals, active investors, and corporate activity.

Jan 20, 2021

Research Brief

Canadian Digital Health Market Map

Covid-19 has propelled digital health into the mainstream. From telehealth to clinical intelligence to AI-enabled drug discovery, these Canada-based startups stand to benefit in a post-Covid world.

Sep 28, 2020

Can Smartphones Help Prevent The Spread Of Infectious Diseases?

Research Brief

Can Smartphones Help Prevent The Spread Of Infectious Diseases?

Smartphones have the potential to hugely increase access to pathogen detection — a critical step in diagnosing and preventing the spread of infectious diseases.

May 14, 2020

40+ Startups Aiding Infectious Disease Care And Containment

Research Brief

40+ Startups Aiding Infectious Disease Care And Containment

Market Map From molecular diagnostics to disinfecting robots, these 40+ startups are looking to change how infectious diseases are prevented, diagnosed, treated, and managed.

Mar 24, 2020

What College Students Taught Us About Predicting Future Tech Trends

Research Brief

What College Students Taught Us About Predicting Future Tech Trends

Our interns used the CB Insights platform to analyze emerging trends in computing, DNA data storage, aviation, and more.

Oct 21, 2019

Your Genomic Data Is More Valuable Than You Think — Failing To Protect It May Have Unintended Consequences

Research Brief

Your Genomic Data Is More Valuable Than You Think — Failing To Protect It May Have Unintended Consequences

On the cusp of a genomics revolution, securing our genetic data is becoming more important than ever. We dig into rising threats and emerging solutions around protecting our most valuable personal data — our DNA.

May 1, 2019

Elizabeth Holmes’ Failed Theranos Was Just Granted 5 New Patents In 2019

Research Brief

Elizabeth Holmes’ Failed Theranos Was Just Granted 5 New Patents In 2019

After being accused of years of fraud, Theranos officially shut down in September 2018. But in March of this year — and just a few months after its death — the company was granted its first blood-testing patent of 2019. Since then, Theranos has been granted 4 additional patents.

Apr 11, 2019

35+ Companies Using Synthetic Biology To Rethink Everything From Plastics To Fabrics To Fertilizers

Research Brief

35+ Companies Using Synthetic Biology To Rethink Everything From Plastics To Fabrics To Fertilizers

Advances in industrial biochemistry have unlocked the potential to harness small cells to make fuel, foods, and custom materials. We looked at startups using cells for factory-scale production.

Nov 8, 2018